The gpII glycoprotein of varicella-zoster virus (VZV) was produced in CV1 cells via vaccinia virus recombinants. Two different DNA constructs were expressed: the first one encodes the complete gpII protein (gpII s+a+) and the second a truncated species lacking the membrane anchorage domain (gpII s+a-). To achieve expression both coding sequences had to be engineered at the 5′ end by substituting the unusually short (24 bp) natural signal sequence by a more conventional one encoding 29 amino acids. Recombinant gpII proteins were detected in vaccinia virus-infected cells by ELISA and immunoprecipitation. Both forms of recombinant gpII proteins were produced as glycosylated single-chain molecules of respectively 110K and 90K. Upon reduction these were only partially converted into subunits. A rabbit infected with the vaccinia virus recombinant expressing the complete gpII produced antibodies which recognized VZV antigens and neutralized VZV infectivity in vitro, independent of complement.
DavisonA. J.,
EdsonC. M.,
EllisR. W.,
ForghaniB.,
GildenD.,
GroseC,
KellerP. M.,
VafaiA.,
WroblewskaZ.,
YamanishiK.1986; New common nomenclature for glycoprotein genes of varicella-zoster virus and their glycosylated products. Journal of Virology 57:1195–1197
EdsonC. M.,
HoslerB. A.,
RespessR. A.,
WatersD. J.,
Thorley-LawsonD. A.1985b; Cross-reactivity between herpes simplex virus glycoprotein B and a 63,000-dalton varicella-zoster virus envelope glycoprotein. Journal of Virology 56:333–336
GroseC.,
EdwardsD. P.,
WeigleK. A.,
FriedrichsW. E.,
McGuireW. L.1984; Varicella-zoster virus specific gpl40: a highly immunogenic and disulfide-linked structural glycoprotein. Virology 132:138–146
KellerP. M.,
DavisonA. J.,
LoweR. S.,
BennettC. D.,
EllisR. W.1986; Identification and structure of the gene encoding gpll, a major glycoprotein of varicella-zoster virus. Virology 152:181–191
ManservigiR.,
GrossiM. P.,
GualandriR.,
BalboniP. G.,
MarchiniA.,
RotolaA.,
RimessiP.,
di LucaD.,
CassaiE.,
Barbanti-BrodanoG.1990; Protection from herpes simplex virus type 1 lethal and latent infections by secreted recombinant glycoprotein B constitutively expressed in human cells with a BK virus episomal vector. Journal of Virology 64:431–136
SarmientoM.,
HaffeyM.,
SpearP. G.1979; Membrane proteins specified by herpes simplex viruses. III. Role of glycoprotein VP7(B2) in virion infectivity. Journal of Virology 29:1149–1158
VafaiA.,
WroblewskaZ.,
WellishM.,
GreenM.,
GildenD.1984; Analysis of three late varicella-zoster virus proteins, a 125,000-molecular-weight protein and gpl and gp3. Journal of Virology 52:953–959
VafaiA.,
WellishM.,
WroblewskaZ.,
CiscoM.,
GildenD.1987; Induction of antibody against in vitro translation products encoded by varicella-zoster virus glycoprotein genes. Virus Research 7:325–333
WilleyD. E.,
CantinE. M.,
HillL. R.,
MossB.,
NotkinsA. L.,
OpenshawH.1988; Herpes simplex virus type 1-vaccinia virus recombinant expressing glycoprotein B. Protection from acute and latent infection. Journal of Infectious Diseases 158:1382–1386